Schizencephaly
|
0.460 |
Biomarker
|
disease |
BEFREE |
No major role for the EMX2 gene in schizencephaly.
|
18409201 |
2008 |
Schizencephaly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
No pathologic mutations were identified in this cohort, suggesting that EMX2 mutations are an uncommon cause of schizencephaly.
|
17506092 |
2007 |
Schizencephaly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous mutations in the EMX2 locus are reported to give rise to schizencephaly.
|
15887302 |
2005 |
Schizencephaly
|
0.460 |
Biomarker
|
disease |
BEFREE |
Review of the genetic studies and the more recent personal data suggests that the role of the EMX2 gene in schizencephaly, if any, is restricted to a minority of cases, leaving the etiopathogenesis of this brain malformation still a matter of study and debate.
|
15921232 |
2005 |
Schizencephaly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Mutations in EMX2 in humans are associated with schizencephaly, not skeletal anomalies.
|
12884444 |
2003 |
Schizencephaly
|
0.460 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We previously reported the presence of EMX2 mutations in 7 out of 8 sporadic cases of schizencephaly.
|
9359037 |
1998 |
Schizencephaly
|
0.460 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We previously reported the presence of EMX2 mutations in 7 out of 8 sporadic cases of schizencephaly.
|
9359037 |
1998 |
Schizencephaly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
The present findings, together with the reported cases of schizencephaly associated with EMX2 mutations, support the hypothesis that, at least in some cases, schizencephalies are determined by deleterious mutations of this homeobox gene.
|
9153481 |
1997 |
Schizencephaly
|
0.460 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The present findings, together with the reported cases of schizencephaly associated with EMX2 mutations, support the hypothesis that, at least in some cases, schizencephalies are determined by deleterious mutations of this homeobox gene.
|
9153481 |
1997 |
Schizencephaly
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Schizencephaly
|
0.460 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Familial schizencephaly
|
0.320 |
Biomarker
|
disease |
BEFREE |
EMX2-independent familial schizencephaly: clinical and genetic analyses.
|
15887302 |
2005 |
Familial schizencephaly
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Familial schizencephaly associated with EMX2 mutation.
|
9153481 |
1997 |
Familial schizencephaly
|
0.320 |
Biomarker
|
disease |
CTD_human |
|
|
|
Malignant neoplasm of lung
|
0.310 |
Biomarker
|
disease |
CTD_human |
Taken together, our study suggests that EMX2 may have important roles as a novel suppressor in human lung cancer.
|
20697358 |
2010 |
Malignant neoplasm of lung
|
0.310 |
Biomarker
|
disease |
BEFREE |
Taken together, our study suggests that EMX2 may have important roles as a novel suppressor in human lung cancer.
|
20697358 |
2010 |
Schizophrenia
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
By qRT-PCR, PLSCR4 and EMX2 were significantly down-regulated in the schizophrenia suicide completers, but could not be confirmed in bipolar disorder.
|
17997842 |
2007 |
Schizophrenia
|
0.310 |
Biomarker
|
disease |
PSYGENET |
By qRT-PCR, PLSCR4 and EMX2 were significantly down-regulated in the schizophrenia suicide completers, but could not be confirmed in bipolar disorder.
|
17997842 |
2007 |
Lung Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
EMX2 is epigenetically silenced and suppresses growth in human lung cancer.
|
20697358 |
2010 |
Female Urogenital Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Development of the mammalian female reproductive tract.
|
16002989 |
2005 |
Agenesis of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral cortical atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Carcinogenesis
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
As EMX2 is reported to play a role in carcinogenesis, we investigated the impact of EMX2 overexpression in glioma-related cell lines.
|
30514244 |
2018 |
Carcinogenesis
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
Taken together, our study demonstrates that EMX2 inhibits proliferation and tumorigenesis through inactivation of the Wnt/β-catenin pathway in CRC cells.
|
27712600 |
2017 |
Carcinogenesis
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
While recent studies provide evidence that EMX2 regulates tumorigenesis of various solid tumors, its role in colorectal cancer remains unknown.
|
28830374 |
2017 |